Loading ...

Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

gemcitabine-loaded amino-functionalized SBA-15 nanorods

Based on

1 Articles
2015 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

silicon dioxide

silicic oxide silica
Type Single Compound
Formula SiO2
Role raw materials
2

[3-(2-aminoethylamino)-propyl]-trimethoxysilane moiety

N-(2-aminoethyl)-3-aminopropyltrimethoxysilane moiety N-[3-(trimethoxysilyl)propyl] ethylenediamine moiety N-[3-(trimethoxysilyl)propyl]-ethylenediamine moiety [3-(2-aminoethylamino)propyl]trimethoxysilane moiety N-[3-(trimethoxysilyl)propyl]ethylenediamine moiety N-[3-trimethoxysilylpropyl]ethylendiamine moiety N-[3-(trioxysilyl)propyl]ethylenediamine moiety (N-β-(aminoethyl)-γ-aminopropyl silane moiety (N-(3-oxysilyl)propyl)ethylenediamine moiety N-(2-aminoethyl)-3-aminopropylsiloxy group [3-(2-aminoethylamino)propyl]trioxysilane -SiO3-(CH2)3-NH-(CH2)2-NH2 3 aminopropylsilane moiety aminosilane moiety en-APTAS moiety AEAPTMS moiety 2APTMS moiety AAPTS moiety TMPED moiety AAPS moiety EDAS moiety TPED moiety APS moiety N-3 moiety
Type Single Compound
Formula -C5H13N2O3Si-
Role graft
3

gemcitabine hydrochloride

Gem
Type Single Compound
Formula C9H12ClF2N3O4
Role loaded material

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
drug release dependent on pH

More information/entries available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
drug delivery

More information available to subscribers only.

Or, view sample content

Characterization

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  1. E6iXx5Kk
  2. eqN91pq1
Product

gemcitabine-loaded amino-functionalized SBA-15 nanorods

Length: ~ 1000 nm

Pore diameter: ~ 6.18 nm

Width: ~ 100 nm

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial